C

CVRx Inc
NASDAQ:CVRX

Watchlist Manager
CVRx Inc
NASDAQ:CVRX
Watchlist
Price: 7.92 USD 3.26% Market Closed
Market Cap: 207.6m USD

CVRx Inc
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

CVRx Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
CVRx Inc
NASDAQ:CVRX
Other Current Liabilities
$135k
CAGR 3-Years
-30%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$330m
CAGR 3-Years
28%
CAGR 5-Years
18%
CAGR 10-Years
27%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Stryker Corp
NYSE:SYK
Other Current Liabilities
$7.4B
CAGR 3-Years
145%
CAGR 5-Years
73%
CAGR 10-Years
38%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.5B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
-1%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$570.5m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
10%
No Stocks Found

CVRx Inc
Glance View

Market Cap
207.5m USD
Industry
Health Care

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. The company is headquartered in Minneapolis, Minnesota and currently employs 109 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its platform technology offers BAROSTIM, designed to control the brain to address the imbalance of the autonomic nervous system (ANS), which causes heart failure (HF) and other cardiovascular diseases. The Company’s product, BAROSTIM NEO, is a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction (HFrEF). BAROSTIM NEO provides baroreflex activation therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. BAROSTIM NEO consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead.

CVRX Intrinsic Value
11.87 USD
Undervaluation 33%
Intrinsic Value
Price
C

See Also

What is CVRx Inc's Other Current Liabilities?
Other Current Liabilities
135k USD

Based on the financial report for Dec 31, 2024, CVRx Inc's Other Current Liabilities amounts to 135k USD.

What is CVRx Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-48%

Over the last year, the Other Current Liabilities growth was 8%. The average annual Other Current Liabilities growth rates for CVRx Inc have been -30% over the past three years , -48% over the past five years .

Back to Top